{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:18Z","timestamp":1789609098749,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jcrc.2017.07.002","type":"journal-article","created":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T11:31:34Z","timestamp":1498908694000},"page":"65-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study"],"prefix":"10.1016","volume":"42","author":[{"given":"Feng","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5905-7760","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcrc.2017.07.002_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2014treatment and outcome","volume":"65","author":"Yamane","year":"2016","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0010","article-title":"Metolazone associated Stevens Johnson syndrome-toxic epidermal necrolysis overlap","volume":"10","author":"Kumar","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"10.1016\/j.jcrc.2017.07.002_bb0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.burns.2009.06.213","article-title":"Toxic epidermal necrolysis (Lyell's disease)","volume":"36","author":"Lissia","year":"2010","journal-title":"Burns"},{"issue":"1","key":"10.1016\/j.jcrc.2017.07.002_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2017.07.002_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D397D8T291","article-title":"Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome","volume":"8","author":"Ghislain","year":"2002","journal-title":"Dermatol Online J"},{"issue":"12","key":"10.1016\/j.jcrc.2017.07.002_bb0030","first-page":"1343","article-title":"Toxic epidermal necrolysis. Therapy in ICU with intravenous immunoglobulins in a case","volume":"128","author":"Andresen","year":"2000","journal-title":"Rev Med Chil"},{"issue":"2","key":"10.1016\/j.jcrc.2017.07.002_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2340\/00015555-0214","article-title":"Dexamethasone pulse therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"87","author":"Kardaun","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jcrc.2017.07.002_bb0040","first-page":"270","article-title":"Systemic corticosteroids in toxic epidermal necrolysis","volume":"62","author":"Dhar","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas","year":"2002","journal-title":"Ther Apher"},{"issue":"12","key":"10.1016\/j.jcrc.2017.07.002_bb0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","article-title":"Plasmapheresis in severe drug-induced toxic epidermal necrolysis","volume":"121","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jcrc.2017.07.002_bb0060","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jcrc.2017.07.002_bb0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/1346-8138.12925","article-title":"Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"42","author":"Aihara","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jcrc.2017.07.002_bb0070","series-title":"F1000Research","article-title":"Toxic epidermal necrolysis","volume":"5","author":"Hoetzenecker","year":"2016"},{"issue":"1","key":"10.1016\/j.jcrc.2017.07.002_bb0075","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.5546\/aap.2013.e24","article-title":"Toxic epidermal necrolysis associated with acute infection by Mycoplasma pneumoniae","volume":"111","author":"Calvano","year":"2013","journal-title":"Arch Argent Pediatr"},{"issue":"6","key":"10.1016\/j.jcrc.2017.07.002_bb0080","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.12607","article-title":"The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre","volume":"169","author":"Lee","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jcrc.2017.07.002_bb0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/1346-8138.13040","article-title":"Clinical profiles and treatment outcomes of systemic corticosteroids for toxic epidermal necrolysis: a retrospective study","volume":"43","author":"Choonhakarn","year":"2016","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.jcrc.2017.07.002_bb0090","first-page":"537","article-title":"Analysis of treatments and deceased cases of severe adverse drug reactions\u2014analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"58","author":"Yamane","year":"2009","journal-title":"Arerugi"},{"issue":"2","key":"10.1016\/j.jcrc.2017.07.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000001221","article-title":"Management of toxic epidermal necrolysis with plasmapheresis and cyclosporine A: our 10years' experience","volume":"5","author":"Giudice","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0100","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1744-9987.2009.00800.x","article-title":"Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis","volume":"14","author":"Szczeklik","year":"2010","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jcrc.2017.07.002_bb0105","first-page":"0","article-title":"Plasmapheresis, intravenous immunoglobulins, and autologous serum eyedrops in the acute eye complications of toxic epidermal necrolysis","volume":"21","author":"Pinna","year":"2017","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5603\/AIT.2015.0034","article-title":"The use of plasmapheresis in a 4-year-old boy with toxic epidermal necrosis","volume":"47","author":"Hinc-Kasprzyk","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0190-9622(99)70497-4","article-title":"Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis","volume":"40","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jcrc.2017.07.002_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1346-8138.2010.01154.x","article-title":"Efficacy of plasmapheresis for the treatment of severe toxic epidermal necrolysis: is cytokine expression analysis useful in predicting its therapeutic efficacy?","volume":"38","author":"Narita","year":"2011","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jcrc.2017.07.002_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0961203308089341","article-title":"Efficacy of plasmapheresis in the treatment of refractory toxic epidermal necrolysis-like acute cutaneous lupus erythematosus","volume":"17","author":"Simsek","year":"2008","journal-title":"Lupus"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944117304343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944117304343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T05:03:33Z","timestamp":1659157413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944117304343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"alternative-id":["S0883944117304343"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.07.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727788499.793575142","asserted-by":"object"}]},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of toxic epidermal necrolysis using plasmapheresis: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}